Canadian and Hong Kong Patents Continue to Strengthen Intellectual Property Protection Across Envoy ...
News Room
White Bear Lake, Minnesota--(Newsfile Corp. - September 2, 2026) -Envoy Medical®Inc. (NASDAQ: COCH) ...
Submitted First Module of Modular PMA Application to FDA
White Bear Lake, Minnesota--(Newsfile Corp. - July 21, 2026) -Envoy Medical® Inc.(NASDAQ: COCH) ("En...
Mean CNC word recognition scores for Stage 1 cohort improved to 53.2% at 12 months from 15.2% pre-im...
Modular Regulatory Strategy Creates Defined Milestone Cadence, Enables Earlier FDA Engagement, and S...
Termination Reflects Company's Confidence in Current Capital Position
White Bear Lake, Minnesota--(Newsfile Corp. - June 18, 2026) -Envoy Medical® Inc. (NASDAQ: COCH) ("E...
White Bear Lake, Minnesota--(Newsfile Corp. - June 4, 2026) -Envoy Medical® Inc. (NASDAQ: COCH), a h...
Australian and European Patent Offices Grant the Company Four Patents Relating to Key Innovations in...
*The materials and resources presented are intended to be an educational resource for general purposes only. They are not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician. Each person’s situation is unique and risks, outcomes, experience and results may vary. CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by federal (or United States) law to investigational use.










